Cite

HARVARD Citation

    Lee, J. et al. (n.d.). Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses. Journal of the National Cancer Institute. p. . [Online]. 
  
Back to record